載入...
A personalized approach to treatment: use of egfr tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer in Canada
Lung cancer is one of the most commonly diagnosed malignancies and the leading cause of cancer-related mortality in Canada. The heterogeneity of nsclc and the importance of linking new targeted agents to the appropriate disease subtype require an individualized approach to treatment. In patients wit...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Multimed Inc.
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3320229/ https://ncbi.nlm.nih.gov/pubmed/22514494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.19.1018 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|